US2008113916A1PendingUtilityA1

Povidone-Containing Carriers for Polypeptide Growth Factors

Assignee: ZIMMER ORTHOBIOLOGIES INCPriority: Oct 16, 1998Filed: Jan 14, 2008Published: May 15, 2008
Est. expiryOct 16, 2018(expired)· nominal 20-yr term from priority
A61P 35/00A61P 9/00A61P 21/00A61K 38/30A61K 9/0014A61K 47/32A61K 38/1858A61K 38/1825A61K 47/58A61K 38/1875A61K 9/0019A61K 38/1841A61K 38/1808
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A liquid carrier medium is provided which is suitable for solubilizing growth factors, such as mixtures of bone morphogenetic proteins, that are found to induce an angiogenic response in ischemic tissues. The liquid medium comprises an aqueous solution of polyvinyl pyrrolidone.

Claims

exact text as granted — not AI-modified
1 - 31 . (canceled)  
     
     
         32 . A method of promoting soft tissue regeneration in a living subject, comprising: 
 administering to the soft tissue a growth factor composition comprising a polypeptide of the TGF-β superfamily and a carrier comprising a vinyl pyrrolidone polymer having a molecular weight of from about 2.5 kD to about 20 kD and a solvent selected from the group consisting of water and aqueous buffer solutions,    wherein the weight ratio of the polypeptide to the vinyl pyrrolidone polymer is 1:10 or less and angiogenesis is induced in the soft tissue.    
     
     
         33 . The method of  claim 32 , wherein the soft tissue comprises myocardial tissue.  
     
     
         34 . The method of  claim 33 , wherein administering comprises injecting the composition into the myocardial tissue.  
     
     
         35 . The method of  claim 34 , wherein the composition is a liquid having a viscosity of less than about 3 cP.

Join the waitlist — get patent alerts

Track US2008113916A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.